retatrutide triple agonist obesity ⭐️topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon hormone receptor agonist, in adults with or “overweight” Retatrutide isn't just another peptide…

Jonah Fox Region: North America English Obesity affects more than 40% of the U.S

The drug is built on Akstons proprietary Fc-fusion platform, which the company says can extend duration of action and streamline development of long-acting protein therapeutics. "Feline obesity is one of the most common yet least effectively treated health issues in veterinary medicine," Zion said

The newer cholesterol-lowering medications, PCSK9 inhibitors, have been shown to lower Lp(a) levels.[ref] A 2026 placebo-controlled clinical trial using the PCSK9 inhibitor enlicitide also showed a decreased in Lp(a) levels at 24 weeks.[ref] Aspirin: A study of over 12,000 people over age 70 looked at the effect of 100mg of aspirin daily

Address : Kyowa Hakko USA, Inc

PMID 26978405